Jibo Medical 2025 Annual Report: Net Profit Attributable to Listed Company Shareholders Up 47%, Orthodontic Revenue Up 24% YoY

Source: Jibo Medical 2025 Annual Report

DentalGoodNews｜On April 24, 2026, Guangdong Jibo Medical Group Co., Ltd. (hereinafter referred to as "Jibo Medical") released its 2025 annual report. The report shows that the company achieved operating revenue of RMB 370 million in 2025, a year-on-year increase of 3.90%; net profit attributable to shareholders of the parent company was RMB 34.1269 million, up 47.14% year-on-year; and the gross margin for 2025 increased from 30.12% in the same period last year to 34.23%.

The company's net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was RMB 32.5874 million, a year-on-year increase of 56.42%. The difference before and after the deduction was RMB 1.5395 million. Other income increased by 61.99% compared to the previous period. The company stated that the main reason was the increase in individual tax refunds and government subsidies received during the period.

Source: Jibo Medical 2025 Annual Report

By business segment, Jibo Medical's dental implantation services generated revenue of RMB 148 million, with gross margin increasing by 5.04 percentage points to 36.12%. The orthodontic treatment business achieved revenue of RMB 48.3075 million, a year-on-year increase of 24.09%, with gross margin also rising to 30.14%. In addition, comprehensive dental treatment and dental restoration services generated revenues of RMB 110 million and RMB 62.8642 million, respectively, with gross margins increasing to 33.27% and 34.96%.

In terms of institutional layout, as of the end of 2025, the company had established 32 dental medical institutions in the Guangdong-Hong Kong-Macao Greater Bay Area, with nearly 250 practicing physicians and over 400 dental chairs. Its business covers core cities such as Foshan, Guangzhou, Zhuhai, Zhongshan, Jiangmen, Zhaoqing, and Dongguan [①P7]. According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), the company had already achieved revenue of RMB 170 million in the first half of 2025 and a 87.36% increase in net profit attributable to shareholders of the parent company.

Source: Jibo Medical 2025 Annual Report

In terms of expense control and costs, the company's selling expenses were RMB 50.426 million, a year-on-year increase of 25.31%. The company stated that this was mainly due to increased market promotion and customer service personnel, as well as higher brand promotion expenses. Administrative expenses, however, decreased to RMB 34.7697 million, a year-on-year reduction of 10.78%. Additionally, due to the termination of operations of the subsidiary Excellence Dental during the period, a loss of RMB 132,400 was incurred from the disposal of fixed assets.

Source: Jibo Medical 2025 Annual Report

In terms of cash flow and financial structure, Jibo Medical's net cash flow from operating activities in 2025 was RMB 88.8768 million, a year-on-year increase of 11.67%. The company's asset-liability ratio (consolidated basis) was 59.96%, flat compared to the end of the previous year. As of December 31, 2025, the company's total assets were RMB 405 million, up 2.64% year-on-year; total liabilities were RMB 243 million, up 2.74% year-on-year; and net assets attributable to shareholders of the parent company were RMB 162 million, up 2.10% year-on-year.

Source: Jibo Medical 2025 Annual Report

In terms of personnel efficiency, the company had a total of 1,145 employees as of the end of 2025, including 880 medical staff, accounting for 76.86% of the total. Based on annual revenue, the company's overall personnel efficiency was approximately RMB 322,800 per person, and the medical staff efficiency was approximately RMB 420,100 per person. In terms of educational background, there were 256 employees with a bachelor's degree or above (including 1 doctoral degree and 13 master's degrees), an increase compared to the end of the previous year.